Aspen Aerogels, Inc. (NYSE:ASPN) Given Average Rating of "Hold" by Brokerages

Key Points

• Analysts' consensus: "Hold" — Seven analysts average a Hold rating (2 sell, 2 hold, 3 buy) with a one‑year target of $4.25, and several firms (TD Cowen, Barclays, Roth MKM) have recently cut price targets.
• Weak financials and guidance — Aspen reported Q EPS of ($0.34), missing estimates by $0.07, with revenue of $41.34M (down 66.4% YoY) and a negative net margin of 143.69%; Q1 2026 EPS guidance is −0.280 to −0.240.
• Stock context — Shares opened at $3.31 (52‑week range $2.30–$9.78), market cap roughly $274M, and institutional ownership is very high at 97.64%.

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have received an average rating of "Hold" from the seven analysts that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $4.25.

ASPN has been the subject of a number of recent research reports. TD Cowen decreased their price target on shares of Aspen Aerogels from $7.00 to $6.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. Barclays decreased their price target on shares of Aspen Aerogels from $4.00 to $3.00 and set an "underweight" rating for the company in a research note on Thursday, March 5th. Zacks Research upgraded shares of Aspen Aerogels from a "strong sell" rating to a "hold" rating in a research note on Thursday, January 15th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Finally, Roth Mkm decreased their price target on shares of Aspen Aerogels from $6.00 to $3.00 and set a "buy" rating for the company in a research note on Thursday, February 26th.

Aspen Aerogels Stock Down 6.2%

Shares of Aspen Aerogels stock opened at $3.31 on Wednesday. Aspen Aerogels has a 52-week low of $2.30 and a 52-week high of $9.78. The company has a 50 day moving average of $3.39 and a 200 day moving average of $4.24. The company has a quick ratio of 3.29, a current ratio of 3.90 and a debt-to-equity ratio of 0.34. The company has a market capitalization of $274.17 million, a P/E ratio of -0.70 and a beta of 2.90.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.07). Aspen Aerogels had a negative return on equity of 13.91% and a negative net margin of 143.69%.The firm had revenue of $41.34 million during the quarter, compared to analysts' expectations of $44.25 million. During the same quarter in the prior year, the firm earned $0.14 EPS. The firm's revenue was down 66.4% compared to the same quarter last year. Aspen Aerogels has set its Q1 2026 guidance at -0.280--0.240 EPS. As a group, research analysts forecast that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Institutional investors have recently modified their holdings of the stock. Acadian Asset Management LLC purchased a new stake in shares of Aspen Aerogels during the 1st quarter worth approximately $43,000. Tower Research Capital LLC TRC lifted its position in shares of Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock worth $43,000 after buying an additional 4,693 shares during the last quarter. Olympiad Research LP purchased a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $70,000. Prelude Capital Management LLC purchased a new stake in shares of Aspen Aerogels during the 3rd quarter worth approximately $70,000. Finally, Balance Wealth LLC purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth approximately $29,000. Hedge funds and other institutional investors own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.